Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 1
2006 1
2008 1
2009 1
2011 2
2012 1
2015 3
2017 1
2018 2
2020 2
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Propiverine Hydrochloride for Overactive Bladder in Adult: a Systematic Review and Meta-analysis.
Huang W, Zong H, Zhou X, Wang T, Zhang Y. Huang W, et al. Indian J Surg. 2015 Dec;77(Suppl 3):1369-77. doi: 10.1007/s12262-015-1264-1. Epub 2015 Apr 4. Indian J Surg. 2015. PMID: 27011567 Free PMC article. Review.
Propiverine also decrease the number of urgency, urgency incontinence, and nocturia and increase urine volume. ...Propiverine add a1-adrenoceptor antagonist was more effective in terms of decreasing difficulty in voiding....
Propiverine also decrease the number of urgency, urgency incontinence, and nocturia and increase urine volume. ...Propiverine …
Efficacy and safety of imidafenacin for overactive bladder in adult: a systematic review and meta-analysis.
Huang W, Zong H, Zhou X, Zhang Y. Huang W, et al. Int Urol Nephrol. 2015 Mar;47(3):457-64. doi: 10.1007/s11255-015-0916-1. Epub 2015 Jan 31. Int Urol Nephrol. 2015. PMID: 25636812 Review.
CONCLUSIONS: This meta-analysis indicates that imidafenacin was similar to propiverine or solifenacin in its efficacy for OAB and was better tolerated than propiverine or solifenacin in the safety for OAB. We conclude that imidafenacin is preferable to propiverin …
CONCLUSIONS: This meta-analysis indicates that imidafenacin was similar to propiverine or solifenacin in its efficacy for OAB and was …
Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis.
Mari A, Antonelli A, Cindolo L, Fusco F, Minervini A, De Nunzio C. Mari A, et al. Ther Adv Urol. 2021 Apr 12;13:1756287221993283. doi: 10.1177/1756287221993283. eCollection 2021 Jan-Dec. Ther Adv Urol. 2021. PMID: 33912246 Free PMC article. Review.
One RCT investigated the clinical outcomes of alfuzosin with finasteride, two with propiverine and two with phosphodiesterase-5 inhibitors. CONCLUSIONS: Alfuzosin is an effective drug for the treatment of LUTS/BPH, with a lower rate of sexual disorders compared with other …
One RCT investigated the clinical outcomes of alfuzosin with finasteride, two with propiverine and two with phosphodiesterase-5 inhib …
Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events?
Paquette A, Gou P, Tannenbaum C. Paquette A, et al. J Am Geriatr Soc. 2011 Jul;59(7):1332-9. doi: 10.1111/j.1532-5415.2011.03473.x. Epub 2011 Jun 30. J Am Geriatr Soc. 2011. PMID: 21718264 Review.
Articles were identified from MEDLINE and EMBASE databases until 2010 using the search terms "clinical trial" AND (one of) "oxybutynin, tolterodine, fesoterodine, propiverine, solifenacin, darifenacin, and trospium." Eligibility criteria included original randomized trials …
Articles were identified from MEDLINE and EMBASE databases until 2010 using the search terms "clinical trial" AND (one of) "oxybutynin, tolt …
The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis.
Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D. Chapple CR, et al. Eur Urol. 2008 Sep;54(3):543-62. doi: 10.1016/j.eururo.2008.06.047. Epub 2008 Jun 20. Eur Urol. 2008. PMID: 18599186 Review.
Improvements were seen in HRQL with treatment by darifenacin, fesoterodine, oxybutynin transdermal delivery system, propiverine extended release (ER), solifenacin, tolterodine ER and immediate release, and trospium. ...
Improvements were seen in HRQL with treatment by darifenacin, fesoterodine, oxybutynin transdermal delivery system, propiverine exten …
Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014).
Oelke M, Becher K, Castro-Diaz D, Chartier-Kastler E, Kirby M, Wagg A, Wehling M. Oelke M, et al. Age Ageing. 2015 Sep;44(5):745-55. doi: 10.1093/ageing/afv077. Epub 2015 Jun 23. Age Ageing. 2015. PMID: 26104505 Free PMC article. Review.
FORTA D (avoid) was assigned to alfuzosin, doxazosin, immediate release oxybutynin, propiverine and terazosin. CONCLUSIONS: dutasteride, fesoterodine and finasteride were classified as beneficial in older persons or frail elderly people (FORTA B). ...
FORTA D (avoid) was assigned to alfuzosin, doxazosin, immediate release oxybutynin, propiverine and terazosin. CONCLUSIONS: dutasteri …
Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults.
Stoniute A, Madhuvrata P, Still M, Barron-Millar E, Nabi G, Omar MI. Stoniute A, et al. Cochrane Database Syst Rev. 2023 May 9;5(5):CD003781. doi: 10.1002/14651858.CD003781.pub3. Cochrane Database Syst Rev. 2023. PMID: 37160401 Review.
Nine anticholinergic drugs were included in these studies: darifenacin; fesoterodine; imidafenacin; oxybutynin; propantheline; propiverine; solifenacin; tolterodine and trospium. No studies were found that compared anticholinergic drugs to no treatment. ...
Nine anticholinergic drugs were included in these studies: darifenacin; fesoterodine; imidafenacin; oxybutynin; propantheline; propiverin …
Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysis.
Nazir J, Kelleher C, Aballéa S, Maman K, Hakimi Z, Mankowski C, Odeyemi I. Nazir J, et al. Neurourol Urodyn. 2018 Mar;37(3):986-996. doi: 10.1002/nau.23413. Epub 2017 Nov 15. Neurourol Urodyn. 2018. PMID: 29140559
Solifenacin 5 mg/day had a statistically significant lower risk of dry mouth compared with darifenacin 15 mg/day, fesoterodine 8 mg/day, oxybutynin extended-release 10 mg/day, oxybutynin immediate-release (IR) 9-15 mg/day, tolterodine IR 4 mg/day, propiverine 20 mg/day, an …
Solifenacin 5 mg/day had a statistically significant lower risk of dry mouth compared with darifenacin 15 mg/day, fesoterodine 8 mg/day, oxy …
Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients - a network meta-analysis.
Su YT, Chen HL, Teoh JY, Chan VW, Wu WJ, Lee HY. Su YT, et al. BMC Urol. 2023 Oct 3;23(1):154. doi: 10.1186/s12894-023-01327-1. BMC Urol. 2023. PMID: 37789333 Free PMC article.
Other add-on medications such as desmopressin, tolterodine, solifenacin, fesoterodine, and propiverine showed positive benefits for most, but not all, outcomes. ...
Other add-on medications such as desmopressin, tolterodine, solifenacin, fesoterodine, and propiverine showed positive benefits for m …
Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly.
Scheife R, Takeda M. Scheife R, et al. Clin Ther. 2005 Feb;27(2):144-53. doi: 10.1016/j.clinthera.2005.02.014. Clin Ther. 2005. PMID: 15811477 Review.
RESULTS: Several anticholinergic drugs are available for the treatment of OAB, including oxybutymn, tolterodine, trospium chloride, and propiverine (not available in the United States). Among the agents reviewed, penetration of the blood-brain barrier (as predicted by lipo …
RESULTS: Several anticholinergic drugs are available for the treatment of OAB, including oxybutymn, tolterodine, trospium chloride, and p …
19 results